CITI Training Practice Exam

The criterion used to determine if a study of an approved drug is exempt from the requirement of an IND is whether the study is not intended to be reported to the FDA to support a new indication or a labeling change. This is because if the study is not intended to provide new information about the drug, it does not need to go through the IND process.

Option A is incorrect because an exception from informed consent would not determine if a study is exempt from the requirement of an IND. This applies to studies where the participants are unable to provide informed consent due to their medical condition.

Option B is incorrect because the route of administration would not determine if a study is exempt from the requirement of an IND. This criterion may be used to assess the risks and benefits of a study, but it does not determine whether the study is required to go through the IND process.

Option D is incorrect because involving more than